The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

Apr. 19, 2018
Applicant:

Far Eastern Memorial Hospital, New Taipei, TW;

Inventor:

Yu-Cheng Lin, New Taipei, TW;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/18 (2017.01); A61K 31/558 (2006.01); A61K 31/726 (2006.01); A61K 38/04 (2006.01); A61K 47/08 (2006.01); A61K 47/42 (2017.01); A61P 1/16 (2006.01);
U.S. Cl.
CPC ...
A61K 47/18 (2013.01); A61K 31/558 (2013.01); A61K 31/726 (2013.01); A61K 38/04 (2013.01); A61K 47/08 (2013.01); A61K 47/42 (2013.01); A61P 1/16 (2018.01);
Abstract

A glucosamine peptide compound or a pharmaceutically acceptable salt thereof are useful for treating liver metabolic disorders, wherein the glucosamine peptide compound may have the structure of Glc-L-Pep, and wherein Glc represents glucosamine moiety, L represents a linker, Pep represents a peptide moiety consisting of two to six amino acid residues, Glc and L are bonded by an ether linkage, and L and Pep are bonded by an amide linkage. The liver metabolic disorders include nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, alcoholic fatty liver disease, alcoholic steatohepatitis, hepatic steatosis, liver fibrosis, cirrhosis or a combination thereof.


Find Patent Forward Citations

Loading…